Sharing Personalized Cancer Medicine
Faculty at the Vanderbilt-Ingram Cancer Center founded MyCancerGenome.org in 2011 to help doctors and researchers track current advances in personalized cancer medicine. This in turn helps healthcare providers find clinical trials that might be able to help their patients and lead to new discoveries.
The list of genetic mutations that affect treatment of different cancers is growing rapidly. My Cancer Genome serves as a web-based feed for the latest research in the field, which means doctors and researchers don’t have to spend a great deal of time hunting through medical journals to find new data.
Patients can also use the site to learn more about their tumor's DNA.
All patients treated for melanoma, lung cancer and breast cancer at Vanderbilt have their tumors tested for genetic mutations. These tests yield data that can help doctors choose more effective treatments and researchers learn more about the genetic workings of cancer.